World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
95
Citations
45816
World Ranking
879
National Ranking
489

Richard T. Wyatt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard T. Wyatt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 236 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard T. Wyatt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard T. Wyatt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 95 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard T. Wyatt is affiliated with the Scripps Research Institute in the United States. Their research primarily focuses on immunology, microbiology, and molecular biology, with contributions spanning medicine as well. The main subfields of study include virology, immunology, molecular biology, radiology, nuclear medicine and imaging, and genetics.

The scientist's work extensively covers topics related to HIV research and treatment, monoclonal and polyclonal antibodies research, immunotherapy and immune responses, immune cell function and interaction, vaccines and immunoinformatics approaches, T-cell and B-cell immunology, as well as RNA interference and gene delivery.

Frequent publication venues in which Richard T. Wyatt has contributed include:

  • Cell Reports
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • Pharmaceutics

Some of the recent papers authored or co-authored by Richard T. Wyatt are:

  • Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity, 2020, Cell Reports
  • mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies, 2024, Frontiers in Immunology
  • Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization, 2021, PLoS Pathogens
  • Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody response, 2023, Frontiers in Immunology
  • Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes, 2022, Pharmaceutics

Richard T. Wyatt collaborates frequently with a number of researchers, including Javier Guenaga, Gabriel Ozorowski, Gunilla B. Karlsson Hedestam, Richard F. Wilson, and Shridhar Bale.

Best Publications

  • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

    Peter D. Kwong;Richard Wyatt;James Robinson;Raymond W. Sweet

  • The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

    Richard Wyatt;Joseph Sodroski

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

    Lijun Wu;Norma P. Gerard;Richard Wyatt;Hyeryun Choe

  • The antigenic structure of the HIV gp120 envelope glycoprotein

    Richard Wyatt;Peter D. Kwong;Elizabeth Desjardins;Raymond W. Sweet

  • A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding

    Carlo D. Rizzuto;Richard Wyatt;Richard Wyatt;Nivia Hernández-Ramos;Nivia Hernández-Ramos;Ying Sun;Ying Sun

  • HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

    Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala

  • HIV vaccine design and the neutralizing antibody problem

    Dennis R Burton;Ronald C Desrosiers;Robert W Doms;Wayne C Koff

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

    Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman

  • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder

  • Structural definition of a conserved neutralization epitope on HIV-1 gp120.

    Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell

  • Structure of a V3-Containing HIV-1 gp120 Core

    Chih-chin Huang;Min Tang;Mei-Yun Zhang;Shahzad Majeed

  • Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry

    Michael Farzan;Tajib Mirzabekov;Peter Kolchinsky;Richard Wyatt

  • Proof of principle for epitope-focused vaccine design

    Bruno Emanuel F. Sousa Correia;John T. Bates;Rebecca J. Loomis;Gretchen Baneyx

  • Energetics of the HIV gp120-CD4 binding reaction

    David G. Myszka;Raymond W. Sweet;Preston Hensley;Michael Brigham-Burke

  • Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope

    Gilad Ofek;Min Tang;Anna Sambor;Hermann Katinger

  • Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.

    R Wyatt;J Moore;M Accola;E Desjardin

  • Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates

    Peter D. Kwong;Richard Wyatt;Shahzad Majeed;James Robinson

  • Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.

    Chih Chin Huang;Son N. Lam;Priyamvada Acharya;Min Tang

  • Broad HIV-1 neutralization mediated by CD4-binding site antibodies

    Yuxing Li;Stephen A Migueles;Brent Welcher;Krisha Svehla

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Joseph Sodroski
Joseph Sodroski Harvard Medical School
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Gunilla B. Karlsson Hedestam
Gunilla B. Karlsson Hedestam Karolinska Institute
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
William R. Schief
William R. Schief Scripps Research Institute
Andrew B. Ward
Andrew B. Ward Scripps Research Institute
Krisha McKee
Krisha McKee National Institute of Allergy and Infectious Diseases
Tongqing Zhou
Tongqing Zhou National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open doors to diverse healthcare careers. Many professionals pivot into nursing roles through online accelerated nursing programs for non nurses, designed to quickly equip individuals with essential clinical skills without requiring prior nursing experience.

If you're considering a fast-track into nursing, accelerated nursing programs provide rigorous yet accessible routes to earning a Bachelor of Science in Nursing (BSN), often in under two years. These are ideal for those who hold a degree in another field but wish to enter nursing swiftly.

For career starters, easiest LPN programs to get into offer foundational training to become Licensed Practical Nurses, bridging the gap between high school and advanced nursing degrees. These programs tend to have flexible criteria, making them attractive to many applicants.

Advancing further, easiest nurse practitioner program options provide pathways to becoming Nurse Practitioners (NPs), integrating advanced clinical practice and immunology knowledge. Choosing programs that balance accessibility with quality is key to career growth in healthcare and immunology-related fields.

Best Scientists Citing Richard T. Wyatt

Trending Scientists

Recently Published Articles